These interim results ended up statistically significant and resulted in ending the demo early to provide antiretroviral therapy to all members from the regular-of-care team by using a CD4 T-cell count of fewer than 350 cells/µL. an extensive laboratory analysis, which include HIV viral load and CD4 lymphocyte checking, is necessary to guide con